Clue
A cloud platform from the Broad Institute for exploring perturbational gene expression and proteomic data.
By Clue · 3.0/5 Value-Position score (estimate)
Positioning guardrails
Best for
- Computational biology and bioinformatics teams that need to query the CMap LINCS L1000 gene expression resource without downloading massive files.
- Drug-discovery and drug-repurposing researchers connecting compound, gene and proteomic signatures to generate new hypotheses.
- Academic and non-profit labs, which can use the data and web apps free of charge.
- Data and software engineers who want programmatic access through the CLUE API, Python library, CLI and Docker images.
Ideal size: 5–50 people · Research organisation with computational biology or cheminformatics capability
Not for
- Teams that need a supported commercial SaaS product with an SLA: clue.io and its tools retire on 31 January 2026 and subscriptions are no longer sold.
- Clinical, diagnostic or other regulated patient-facing workflows; CLUE is a research data and analysis platform.
- Buyers looking for packaged analytics over non-biological business data.
- Organisations with no bioinformatics or data-engineering capability, since interpreting perturbation signatures requires domain expertise.
Value metrics scorecard
Time-to-Value
Days for data access; weeks for integration
~30 days to first production value
Total Cost of Ownership
On request
Freely available to academic users; drug-discovery companies previously bought a subscription. The pricing page now returns 404 and subscriptions are discontinued.
Implementation Friction
2/5
Engineering + admin effort required
Value-Position score
out of 5 · model estimate
Full cost breakdown
Mandatory implementation fee
None
Seat tiers
Not published; no seat tiers are documented and subscriptions are discontinued.
Add-on costs
- None
Company & support
Who is behind Clue, and how your team gets help once it is live.
Company
- Founded
- Not recorded
- Headquarters
- Not recorded
How you get support
- PhoneNot listed
- EmailNot listed
- Live chatNot listed
- Support portal / ticketsNot listed
- Community forumNot listed
- Help centre / docsAll plans
- Dedicated account managerNot listed
- In person / on-siteNot listed
- Hours
- Not recorded
- Response time
- Not stated
Clue's support entry point is Connectopedia, its knowledge base. No support tiers, hours or response-time commitments are published, and platform retirement on 31 January 2026 further limits support.
“Not listed” means the vendor’s public pages don’t mention that channel, not that it is unavailable. Ask about it during evaluation.
Market position
Where Clue sits against its closest alternatives. Pick any two of cost, speed, friction and buyer score, and up to 9 companies to compare.
Quadrant view
Typical annual cost × Time-to-value
The lines cross at the median of the solutions shown, so about half sit on each side of each line.
Companies on the chart 6 / 10
- Clue
- Tebra
- Open Dental
- Suki
- Dentrix
- DrChrono
Add or change companies
Up to 10 companies including Clue. Listed closest first.
Stack fit signal
Compatibility with standard B2B ecosystems.
No supported MCP path today, so it cannot be driven from an AI client.
AI & MCP readiness
What Clue ships in AI, and what it asks of your ecosystem.
Compliance attestations
* IAPP AIGP certifies individuals, not products. It means named staff hold the credential — not that the platform does.
Bottom line
CLUE (clue.io) is a cloud platform from the Broad Institute for exploring perturbation-driven gene expression (L1000) and proteomic (P100/GCP) data. It pairs the CMap LINCS dataset with web apps (Touchstone, Query, Proteomics Query, Morpheus, Repurposing) and programmatic access via API, CLI, Python library and Docker. Academic users get data and tools free; commercial drug-discovery teams previously paid a subscription. clue.io announced retirement on 31 January 2026, with public data remaining available at GEO.
Frequently asked questions
What does Clue actually do?
CLUE is a cloud-based platform for analysing perturbational datasets generated with gene expression (L1000) and proteomic (P100 and GCP) assays. It gives researchers integrated access to the CMap LINCS dataset, harmonised results, and web apps such as Touchstone, Query, Proteomics Query, Morpheus and Repurposing, so they can explore hypotheses without downloading and formatting massive files themselves.
What does Clue cost?
Data and tools are freely available to academic users. Drug-discovery companies previously had to buy a subscription to use CLUE for proprietary research while keeping their own data confidential. The pricing page now returns a 404 and the vendor states that subscriptions are no longer offered, so no list price is currently published.
Is Clue still available to buy or use in 2026?
The vendor states that effective 31 January 2026 the clue.io site, including its tools, is retired due to financial constraints, and subscriptions are no longer offered. Publicly available data will remain accessible at GEO, so existing analyses can continue but new commercial adoption is not possible.
Can we integrate Clue into our own analysis pipelines?
Yes. CLUE documents an API providing metadata about compounds, genes, cell lines and signatures, command line interfaces for computational biologists, a Python library for programmatic data access, code libraries and notebooks, and Docker containers for running common analysis algorithms.
Do we need our own bioinformatics team to use Clue?
Meaningful use assumes scientific and computational capability. The platform was explicitly built to lower the barrier for biologists through web apps with graphical interfaces, but interpreting connectivity results, harmonising assays and building production pipelines still requires bioinformatics or data-engineering skills.
How does Clue handle security and compliance?
No security, trust or compliance page is published, and the vendor makes no SOC 2, ISO 27001, HIPAA, FedRAMP or other certification claims on its site. Buyers with regulated data should treat CLUE as an academic research platform rather than a certified enterprise system.